Free tool
GTHRX and FHLC: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between GTHRX and FHLC
54% of their top holdings overlap by weight, with 10 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that FHLC holds far more positions (337 vs 82), so it is broader beyond the top names.
| Holding | % of GTHRX | % of FHLC |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.35% |
| Johnson & Johnson | 6.76% | 8.93% |
| UnitedHealth Group Inc. | 6.17% | 5.44% |
| Merck & Co., Inc. | 4.59% | 4.66% |
| AbbVie Inc. | 4.03% | 6.42% |
| Gilead Sciences, Inc. | 3.63% | 2.34% |
| CVS Health Corp. | 2.52% | 1.92% |
| Cardinal Health, Inc. | 2.10% | 0.78% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.76% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.09% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized